key: cord-0866388-i26whzqg authors: Egilmezer, Ece; Walker, Gregory J.; Bakthavathsalam, Padmavathy; Peterson, Joshua R.; Gooding, J. Justin; Rawlinson, William; Stelzer‐Braid, Sacha title: Systematic review of the impact of point‐of‐care testing for influenza on the outcomes of patients with acute respiratory tract infection date: 2018-08-13 journal: Rev Med Virol DOI: 10.1002/rmv.1995 sha: b58940f7756058fdb940f4fab7e4852313c09d20 doc_id: 866388 cord_uid: i26whzqg Acute respiratory tract infections are a major cause of morbidity and mortality and represent a significant burden on the health care system. Laboratory testing is required to definitively distinguish infecting influenza virus from other pathogens, resulting in prolonged emergency department (ED) visits and unnecessary antibiotic use. Recently available rapid point‐of‐care tests (POCT) may allow for appropriate use of antiviral and antibiotic treatments and decrease patient lengths of stay. We undertook a systematic review to assess the effect of POCT for influenza on three outcomes: (1) antiviral prescription, (2) antibiotic prescription, and (3) patient length of stay in the ED. The databases Medline and Embase were searched using MeSH terms and keywords for influenza, POCT, antivirals, antibiotics, and length of stay. Amongst 245 studies screened, 30 were included. The majority of papers reporting on antiviral prescription found that a positive POCT result significantly increased use of antivirals for influenza compared with negative POCT results and standard supportive care. A positive POCT result also led to decreased antibiotic use. The results of studies assessing the effect of POCT on ED length of stay were not definitive. The studies assessed in this systematic review support the use of POCT for diagnosis of influenza in patients suffering an acute respiratory infection. Diagnosis using POCT may lead to more appropriate prescription of treatments for infectious agents. Further studies are needed to assess the effect of POCT on the length of stay in ED. Acute respiratory tract infections are a major cause of morbidity and mortality and represent a significant burden on the health care system. Laboratory testing is required to definitively distinguish infecting influenza virus from other pathogens, resulting in prolonged emergency department (ED) visits and unnecessary antibiotic use. Recently available rapid point-of-care tests (POCT) may allow for appropriate use of antiviral and antibiotic treatments and decrease patient lengths of stay. We undertook a systematic review to assess the effect of POCT for influenza on three outcomes: (1) antiviral prescription, (2) and approximately 250 000 to 500 000 deaths annually. 6 The current reference standard laboratory test for influenza diagnosis is quantitative reverse transcription PCR. Viral culture 7, 8 is now uncommon, as it is time consuming and expensive and requires specifically trained operators. [9] [10] [11] New rapid diagnostic tests forinfluenza are available that show sensitivity and specificity comparable to real-time PCR assays 12, 13 (Figure 1 ). We aimed to systematically review the literature to determine the effects of point-of-care testing for influenza on outcomes for patients, including (1) use of antivirals for influenza virus, (2) OR "exp Point of Care Systems" [MeSh] OR "rapid test" OR "ridt" OR "radt" OR "influenza A rapid test." The search terms for antivirals were "exp Antiviral Agents" [MeSh] OR "Oseltamivir" [MeSh] OR "antiviral ther*." For antibiotics, we used the search terms "exp Anti-Bacterial Agents" [MeSh] OR "antibiotic*" OR "antibacterial*." The search terms used for length of stay were "exp Length of Stay" [MeSh] OR "LOS." Two reviewers (G.W. and S.S.B.) independently screened the title and abstracts of articles that were eligible using the above criteria. These were supplemented with additional papers that were searched manually using the references of the suitable articles. In cases where there was uncertainty about the eligibility and relevance of a particular article, a resolution was achieved through consensus between reviewers. We excluded scientific review articles, commentaries, Cochrane reviews, case studies, case series studies, analytical model studies, conference abstracts, and studies involving surveys. Studies published only in English were considered. Studies were eligible for inclusion if they assessed the effect of POCT on the clinical management of the patient presenting to a physician in a hospital, acute medical centre, or house visit with influenza-like illness (ILI). For this review, a POCT was defined as a commercially available diagnostic assay that detects influenza in respiratory FIGURE 1 Generalised steps in different methods of diagnostic testing for influenza. POC, point of care; POCT, point of care tests; RT-qPCR, quantitative reverse transcription PCR samples. For a test to be considered as a POCT, it needed to be conducted immediately after specimen acquisition. Studies that did not specify when the test was performed were excluded, as they were presumed to not have been done at point of care. Tests that were not commercially available and that were used in routine influenza diagnosis such as enzyme-linked immunosorbent assay serology were not included in this definition. Studies that used as reference standards viral cell culture, nucleic acid test, immunofluorescence, or diagnosis based on patient symptoms and signs were eligible. For this systematic review, papers were excluded if the results of the POCT were withheld from the health care professional and not used for diagnosis. Attempts were made to contact authors if information or data were lacking in order to construct the tables. The searches were performed by two investigators separately (G.W. and S.S.B.), with quality of the data assessed by two investigators according to Oxford Centre for Evidence-based Medicine (OCEBM) guidelines. 15 Papers included in this systematic review were eligible to be graded from levels 2 to 4 of the OCEBM Levels of Evidence. We considered a level 2-graded study as "excellent" quality, level 3 as "good," and level 4 as "fair." 3 | RESULTS The database search yielded 245 publications after removal of duplicates ( Figure 2 ). Titles and abstracts were screened, and 90 papers were assessed for further eligibility. Additional 10 studies were found through citation of relevant publications in the assessed papers. After full text assessment of study methods and outcomes, a total of 30 met the selection criteria and were included in this systematic review. Using the OCEBM Levels of Evidence Table, 15 nine studies were graded level 2 or excellent quality, 12 were graded level 3 or good quality, and nine were graded level 4 or fair quality (Table S1 , found in the Supporting Information). Results between studies of differing levels of evidence were examined qualitatively, and similar trends were observed between studies. The included studies consisted of retrospective; prospective; and There were 14 publications that measured the effect of POCT on antiviral prescription (Table 1 ). Of these, 12/14 (86%) reported increased antiviral use associated with a positive diagnosis by POCT. A recent randomised controlled trial by Brendish et al 16 Twenty-six studies assessed the effect of POCT on antibiotic prescription rates ( Nine studies assessed the effect of POCT on ED length of stay (Table 3) . Five (55.6%) of these reported significant reductions in time spent in ED in association with POCT use. and patients randomly received either a POCT (n = 60) or standard care (n = 33) following a nasopharyngeal swap that was taken for laboratory confirmation. 29 Sri Lanka A prospective two phase study in the outpatient department of a Sri Lankan hospital. During the first phase (Mar-Dec 2013), patients were attended by physicians who were not aware of their POCT results (n = 316 attributed longer ED stay to the significantly older age of their POCT cohort that may have had more comorbidities, whilst reasons for the other study are unclear. 33 Emergency department LOS can be influenced by many factors including availability of beds, overcrowding, admission and discharge procedures, and the efficiency of ED staff. Thus, it may be that the benefits of POCT in terms of ED LOS are somewhat diminished and that this is reflected in the mixed findings of publications in this systematic review. Nonetheless, studies finding reduced ED stay associated with POCT are encouraging, as this can lead to improved clinical outcomes through prevention of nosocomial spread, and easing burden on the healthcare system. More significant reductions in ED LOS can likely be established by further monitoring as health care centres become more familiar with POC technologies. Early antigen-based POC tests are poor in terms of sensitivity, such as the Quikvue influenza test, which has a sensitivity of 74.0%, and a negative predictive value of 75.0%. 34 Physicians are in many cases aware of such limitations and used confirmatory tests to avoid false-negative results. 18 Nonetheless, the findings of studies in this systematic review suggest that antigen-based POCTs can still significantly affect clinical decision-making and patient outcomes. Newer molecular-based POCTs boast high sensitivity and specificity, meaning that results can be trusted by physicians. Some of the studies using newer molecular POCT saw a limited effect on antibiotic prescription rates, with one group suggesting 16 that in many cases, antibiotics were administered very early in patient assessment, even before POCT results were available. An outcome measuring the proportion of patients treated with brief courses of antibiotics may be more clinically relevant in these cases. At times, molecular POCTs were performed by research investigators rather than clinical staff, 16, 40 suggesting that the study protocol was not ini- in this systematic review were thoroughly checked. Two studies 40, 41 declared potential conflicts of interest, as they were financially supported by commercial manufacturers of POCT, and three others 19, 20, 45 disclosed professional relationships between contributing authors and such companies. A limitation of this systematic review is that its focus is restricted to (1) influenza diagnosis only and (2) antiviral, antibiotic, and LOS outcomes. Whilst these outcomes are highly applicable for influenza management, new molecular POCTs such as the FilmArray Respiratory Panel can test for a range of viruses and bacteria simultaneously. Hence, these technologies have the potential to affect variables not covered in this review, and this is an area that may be targeted by future research. In the past decade, numerous studies reporting the diverse use of nanoparticles in POCT have received great interest because of their unique chemical and physical properties. 51 Several research groups have proposed simple colorimetric approaches based on controlled assembly of gold nanoparticles on the surface of viruses, including influenza. 52, 53 The limit of detection of these proposed methods is up to 385 times lower than that of conventional enzyme-linked immunosorbent assay. 54 Listed by year of publication, alphabetical. b Also assessed antiviral prescription (Table 1) . c Also assessed antibiotic prescription (Table 2) . World Health Organisation. Top 10 causes of death fact sheet No. 310 Middle East respiratory syndrome virus pathogenesis Pathology and pathogenesis of severe acute respiratory syndrome The pathology of influenza virus infections Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma Diagnosis of influenza virus WHO recommendations on the use of rapid testing for influenza diagnosis Review of rapid diagnostic tests for influenza Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the advisory committee on immunization practices (ACIP) Accuracy of rapid influenza diagnostic tests: a meta-analysis Performance characteristics of Xpert Flu/RSV XC assay Charnot-Katsikas A. Comparison of Cepheid Xpert flu/RSV XC and BioFire FilmArray for detection of influenza a, influenza B, and respiratory syncytial virus Reprint-preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement The Oxford levels of evidence Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial Rapid influenza diagnostic tests improve suitability of antiviral treatment in hospitalized children Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department A national study of the impact of rapid influenza testing on clinical care in the emergency department Effect of rapid influenza testing on the clinical management of paediatric influenza Effect of rapid influenza diagnostic testing on antiviral treatment decisions for patients with influenza-like illness: southwestern Evaluation of a direct test for seasonal influenza in outpatients The association between influenza treatment and hospitalization-associated outcomes among Korean children with laboratory-confirmed influenza Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an emergency department Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses Influence of rapid influenza test on clinical management of children younger than five with febrile respiratory tract infections Effect of the influenza virus rapid antigen test on a physician's decision to prescribe antibiotics and on patient length of stay in the emergency department The effect of rapid diagnostic testing for influenza on the reduction of antibiotic use in paediatric emergency department Use of rapid influenza testing to reduce antibiotic prescriptions among outpatients with influenza-like illness in southern Sri Lanka Impact of rapid influenza PCR testing on hospitalization and antiviral use: a retrospective cohort study Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial Effect of a rapid influenza diagnosis The effect of the rapid antigen test for influenza on clinical practice in the emergency department: a comparison of periods before and after the 2009 H1N1 influenza pandemic Impact of rapid influenza diagnostic test on physician estimation of viral infection probability in paediatric emergency department during epidemic period Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection The influence of rapid influenza diagnostic testing on antibiotic prescribing patterns in rural Thailand Impact of rapid diagnosis on management of adults hospitalized with influenza Rapid diagnosis of influenza infection in older adults: influence on clinical care in a routine clinical setting An algorithm to diagnose influenza infection: evaluating the clinical importance and impact on hospital costs of screening with rapid antigen detection tests Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use Effect of point-of-care influenza testing on management of febrile children Ability of physicians to diagnose influenza and usefulness of a rapid influenza antigen test in febrile returning travelers: a randomized controlled trial Impact of rapid influenza testing at triage on management of febrile infants and young children Economic impact of a new rapid PCR assay for detecting influenza virus in an emergency department and hospitalized patients Impact of a rapid respiratory panel test on patient outcomes Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses The impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization Advanced nanotechnologies in avian influenza: current status and future trends-a review Colorimetric detection of influenza A virus using antibody-functionalized gold nanoparticles Detection and differentiation of influenza viruses with glycan-functionalized gold nanoparticles Enhanced catalytic activity of gold nanoparticle-carbon nanotube hybrids for influenza virus detection The authors have no competing interest.